Nuclear receptors and their selective pharmacologic modulators (Q26825692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Nuclear receptors and their selective pharmacologic modulators (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kristine Griffett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Laura A Solt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yongjun Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christine Crumbley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Subhashis Banerjee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Thomas Lundasen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Travis Hughes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Douglas J Kojetin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Pharmacological Reviews

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

65

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

710-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Association of activated vitamin D treatment and mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

THE ISOLATION IN CRYSTALLINE FORM OF THE COMPOUND CONTAINING IODIN, WHICH OCCURS IN THE THYROID

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

New Insights on the Mechanism of PPAR‐targeted Drugs

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Metabolic effects and therapeutic applications of triiodothyropropionic acid

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Centchroman--a non-steroidal anti-cancer agent for advanced breast cancer: phase-II study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mechanisms of intestinal calcium absorption

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Novel hormone "receptors".

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Overcoming resistance to fulvestrant (ICI182,780) by downregulating the c-ABL proto-oncogene in breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery of nonsteroidal androgens

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural studies on nuclear receptors.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Transthyretin: a review from a structural perspective.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prevalence of vitamin D insufficiency in an adult normal population

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy and safety of bazedoxifene in postmenopausal Asian women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1,25 dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female rats.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptors as therapeutic targets in metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The multifunctional estrogen receptor-alpha F domain

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Update on emergency contraception

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Biochemical properties of the 1 alpha, 25-dihydroxyvitamin D3 cytoplasmic receptors from human and chick parathyroid glands

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estradiol-receptors of the rat uterus: Interaction of the cytoplasmic estrogen-receptor with DNA in vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen-induced synthesis of ovalbumin messenger RNA and its translation in a cell-free system

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Serum lipids in hyper- and hypothyroidism before and after treatment

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of 3,4-trans-2, 2-dimethyl-3-phenyl-4-p-(β -pyrrolidinoethoxy) phenyl -7-methoxy chroman (centchroman) on the biochemistry of the fallopian tube and uterus of rhesus monkeys ()

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacokinetics of centchroman in healthy female subjects after oral administration.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Specific effect of estrogens on an interaction between the uterine estradiol receptor and DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Some properties of a nuclear binding site of estradiol

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The interaction of uterine estrogen receptors with DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Biochemical properties of 1 alpha, 25-dihydroxyvitamin D receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Influence of 16 alpha, 17 alpha-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Biochemical and physiological mechanisms in glucocorticoid hormone induction of mouse mammary tumor virus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The interaction of estradiol-receptor protein with the genome: an argument for the existence of undetected specific sites

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Steroid hormone receptors compete for factors that mediate their enhancer function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Distinct classes of transcriptional activating domains function by different mechanisms

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The RXR heterodimers and orphan receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

NER, a new member of the gene family encoding the human steroid hormone nuclear receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mutual cross-modulation of steroid/retinoic acid receptor and AP-1 transcription factor activities: a novel property with practical implications

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PPARs and molecular mechanisms of transrepression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

New insights into thyroid hormone action.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Benzoyl 2-methyl indoles as selective PPARgamma modulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Improving the developability profile of pyrrolidine progesterone receptor partial agonists

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia–reperfusion in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular chaperones throughout the life cycle of the androgen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Oestrogen receptor splice variants in the pathogenesis of disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The expanding cosmos of nuclear receptor coactivators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

SnapShot: NR Coregulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The flip side: Identifying small molecule regulators of nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

INT131: a selective modulator of PPAR gamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DT56a stimulates gender-specific human cultured bone cells in vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The role of the polyglutamine tract in androgen receptor.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A contemporary understanding of progesterone receptor function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The effect of the new SERM arzoxifene on growth and gene expression in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A new MCF-7 breast cancer cell line resistant to the arzoxifene metabolite desmethylarzoxifene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-inflammatory functions of glucocorticoid-induced genes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Folding of the glucocorticoid receptor N-terminal transactivation function: dynamics and regulation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The role of progesterone signaling in the pathogenesis of uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The immninent dawn of SPRMs in obstetrics and gynecology

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Modulation of liver X receptor signaling as a prevention and therapy for colon cancer.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Modulation of estrogen receptor transactivation and estrogen-induced gene expression by ormeloxifene-a triphenylethylene derivative

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Partial agonists activate PPARgamma using a helix 12 independent mechanism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D receptor found in human sperm.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Expression of estrogen receptor coregulators in normal and malignant human endometrium

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

T0901317 is a dual LXR/FXR agonist

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tissue-specific stimulation of RNA synthesis by transformed estradiol-receptor complex

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning, structure and expression of a cDNA encoding the human androgen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Designer glucocorticoids

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mechanisms of action of mifepristone when used for emergency contraception

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Arzoxifene as therapy for endometrial cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A unified nomenclature system for the nuclear receptor superfamily

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DNA binding of the glucocorticoid receptor is not essential for survival

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Combinatorial control of gene expression by nuclear receptors and coregulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

SRC-1 and TIF2 control energy balance between white and brown adipose tissues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Optimised glucocorticoid therapy: the sharpening of an old spear

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Triglyceride metabolism in thyroid disease.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Review of the unique properties of budesonide

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

https://api.crossref.org/works/10.1124%2FPR.112.006833

1 reference

7 January 2021

The LXRs: a new class of oxysterol receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Coactivator and corepressor complexes in nuclear receptor function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tamoxifen versus toremifene in the adjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Arzoxifene in breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Target specificity of selective estrogen receptor modulators within human endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Analysis of glucocorticoid signalling by gene targeting

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

X-ray crystallographic and functional studies of thyroid hormone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

In vivo function of VDR in gene expression-VDR knock-out mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Syntheses and preventive effects of analogues related to 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) on bone mineral loss in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural insights into the mode of action of a pure antiestrogen

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor coregulators: multiple modes of modification

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dissecting human adrenal androgen production

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular basis of resistance to thyroid hormone.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Soft steroids: a new approach to the treatment of inflammatory airways diseases

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Interaction of glucocorticoids with rat liver nuclei. II. Studies on the nature of the cytosol transfer factor and the nuclear acceptor site.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antifertility agents. 38. Effect of the side chain and its position on the activity of 3,4-diarylchromans

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural determinants of selective thyromimetics

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a rec

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A selective estrogen receptor modulator for the treatment of hot flushes.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mell

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

High performance liquid chromatographic (HPLC) determination of centchroman in human serum and application to single-dose pharmacokinetics

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Altered Gene Expression during Differentiation : Population Changes in Hybridizable RNA after Stimulation of the Chick Oviduct with Oestrogen

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of Substrates and Isolation of Microorganisms responsible for Ethylene Production in the Soil

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prospects for Science in Japan

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differences between oestrogen receptor activation by oestrogen and antioestrogen.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Atomic structure of progesterone complexed with its receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Primary structure and expression of a functional human glucocorticoid receptor cDNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The c-erb-A protein is a high-affinity receptor for thyroid hormone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The c-erb-A gene encodes a thyroid hormone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of a receptor for the morphogen retinoic acid

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of a new class of steroid hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

COUP transcription factor is a member of the steroid receptor superfamily

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Interaction of thyroid-hormone receptor with a conserved transcriptional mediator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

MIF as a glucocorticoid-induced modulator of cytokine production

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A structural role for hormone in the thyroid hormone receptor.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Functional interactions between Stat5 and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Steroidal and triterpenoidal fungal metabolites as ligands of liver X receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The role of exercise and PGC1alpha in inflammation and chronic disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone receptor beta is essential for development of auditory function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A role for central nervous system PPAR-γ in the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PXR, CAR and drug metabolism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

PPARγ: a circadian transcription factor in adipogenesis and osteogenesis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A canonical structure for the ligand-binding domain of nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular recognition of nitrated fatty acids by PPARγ

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fulvestrant: pharmacokinetics and pharmacology

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Interaction of androgenic steroids with prostatic chromatin

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A reconstituted cell-free system for the specific transfer of steroid–receptor complexes into nuclear chromatin isolated from rat ventral prostate gland

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Early effects of oestradiol-17β on the chromatin and activity of the deoxyribonucleic acid-dependent ribonucleic acid polymerases (I and II) of the rat uterus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The thyroid hormone analogue SKF L-94901: nuclear occupancy and serum binding studies

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKD

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone receptor antagonists and the endometrial antiproliferative effect

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

https://api.crossref.org/works/10.1124%2FPR.112.006833

1 reference

7 January 2021

Early pregnancy termination with mifepristone and misoprostol in the United States

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Lasofoxifene in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ulipristal acetate versus leuprolide acetate for uterine fibroids

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ulipristal acetate versus placebo for fibroid treatment before surgery

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A fully dissociated compound of plant origin for inflammatory gene repression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Conformational disturbance in Abl kinase upon mutation and deregulation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Early estrogen action: concomitant stimulations within two minutes of nuclear RNA synthesis and uptake of RNA precursor by the uterus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The role of chromatin in estrogen action in the uterus, I. The control of template capacity and chemical composition and the binding of H3-estradiol-17 beta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Studies on the mechanism of estrogen-mediated tissue differentiation: regulation of nuclear transcription and induction of new RNA species

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Chromosomal receptor for a vitamin D metabolite

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Soluble complexes between steroid hormones and target-tissue receptors bind specifically to target-tissue chromatin

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ovalbumin Messenger RNA of Chick Oviduct: Partial Characterization, Estrogen Dependence, and Translation In Vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen-induced changes in translation, and specific messenger RNA levels during oviduct differentiation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Rates of Induction of Specific Translatable Messenger RNAs for Ovalbumin and Avidin by Steroid Hormones

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Receptors from glucocorticoid-sensitive lymphoma cells and two clases of insensitive clones: physical and DNA-binding properties

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning of the human estrogen receptor cDNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning of the chicken progesterone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning and expression of full-length cDNA encoding human vitamin D receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Characterization and expression of a cDNA encoding the human androgen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Alpha and beta thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARgamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen receptors alpha and beta form heterodimers on DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Localizing the membrane binding region of Group VIA Ca2+-independent phospholipase A2 using peptide amide hydrogen/deuterium exchange mass spectrometry

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of a Novel Set of Genes Regulated by a Unique Liver X Receptor-α-mediated Transcription Mechanism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gamma.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Endemic cretinism: toward a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Resistance to thyroid hormone: an historical overview

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The thyroxine-binding proteins

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Metabolic effects of thyroid hormone derivatives.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

TSH regulation dynamics in central and extreme primary hypothyroidism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structural basis of VDR-DNA interactions on direct repeat response elements

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Crystal structure of the heterodimeric complex of LXR and RXR ligand-binding domains in a fully agonistic conformation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synergy between estrogen receptor alpha activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A role for endogenous glucocorticoids in wound repair

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Future use of clomiphene in ovarian stimulation. Will clomiphene persist in the 21st century?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Development, pharmacology and clinical experience with clomiphene citrate

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A pharmacological review of selective oestrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D and bone health

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antimutagenic effects of centchroman--a contraceptive and a candidate drug for breast cancer in multiple mutational assays

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anniversary: 50 years of glucocorticoid treatment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Changes in Serum TSH and Free T4 during Human Sleep Restriction

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A dissociation of thyroid hormonal effects by structural alterations of the thyroxine molecule

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Clinical utility of progesterone receptor modulators and their effect on the endometrium

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Designing the ideal selective estrogen receptor modulator--an achievable goal?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective androgen receptor modulators as function promoting therapies

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure and specificity of nuclear receptor-coactivator interactions

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Role of LXRs in control of lipogenesis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

LXR, a nuclear receptor that defines a distinct retinoid response pathway

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Human steroid receptors and erbA proto-oncogene products: members of a new superfamily of enhancer binding proteins

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The 2.0 Å crystal structure of the ERα ligand-binding domain complexed with lasofoxifene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

3H-oestradiol uptake in vivo by human uterine endometrium: effect of tamoxifen (I.C.I. 46,474).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of clomiphene and raloxifene on gonadotrophin secretion in postmenopausal women: evidence of nongenomic action

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The coactivator LXXLL nuclear receptor recognition motif.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DT56a (Femarelle) stimulates bone formation in female rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Anti-inflammatory and some other pharmacological effects of 3,4-trans-2,2-dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)-phenyl)-7-methoxy-chroman (Centchroman).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Calcipotriol: a new drug for topical psoriasis treatment

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A natural product ligand of the oxysterol receptor, liver X receptor.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen signaling: a subtle balance between ER alpha and ER beta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery and therapeutic promise of selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Overview of nomenclature of nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen-binding substances of target tissues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen-dependent increase in transfer RNA during differentiation of the chick oviduct

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dexamethasone stimulation of murine mammary tumor virus expression: a tissue culture source of virus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular cloning of the chicken progesterone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of human glucocorticoid receptor complementary DNA clones by epitope selection

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Orphan nuclear receptors: shifting endocrinology into reverse

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of a nuclear receptor for bile acids

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bile acids: natural ligands for an orphan nuclear receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peptide antagonists of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptors and lipid physiology: opening the X-files

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular cloning of complementary DNA encoding the avian receptor for vitamin D.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sequence and expression of human estrogen receptor complementary DNA

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The dawn of the SPPARMs?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand-Dependent and -Independent Transactivation by Thyroid Hormone Receptor β2 Is Determined by the Structure of the Hormone Response Element

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Heterodimeric interaction between retinoid X receptor alpha and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Cloning and characterization of two novel thyroid hormone receptor beta isoforms

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Functional interference between thyroid hormone receptor alpha (TRalpha) and natural truncated TRDeltaalpha isoforms in the control of intestine development.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Note on the Treatment of Myx dema by Hypodermic Injections of an Extract of the Thyroid Gland of a Sheep

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Coronary heart disease: an older woman's major health risk

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fat and beyond: the diverse biology of PPARgamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The mechanism of action of thyroid hormones

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand control of coregulator recruitment to nuclear receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Oxysterols: modulators of cholesterol metabolism and other processes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Physiological and molecular basis of thyroid hormone action

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Genetic manipulations of PPARs: effects on obesity and metabolic disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Percutaneous absorption of methylprednisolone aceponate following topical application of Advantan lotion on intact, inflamed and stripped skin of male volunteers

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Toll-like receptors, endocrine stress response, and arteriosclerosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The metabolic effects of the acetic and propionic acid analogs of thyroxine and triiodothyronine

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The ionic control of 1,25-dihydroxyvitamin D3 synthesis in isolated chick renal mitochondria. The role of calcium as influenced by inorganic phosphate and hydrogen-ion

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptors as integrators of metabolic and inflammatory signaling

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synthetic LXR agonists increase LDL in CETP species

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The thyromimetic T-0681 protects from atherosclerosis.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Are side-chain oxidized oxysterols regulators also in vivo?

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Population pharmacokinetics of telapristone (CDB-4124) and its active monodemethylated metabolite CDB-4453, with a mixture model for total clearance.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Biological Actions of Androgens

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Expression of thyroid hormone receptor beta 2 in rat hypothalamus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Characterization of iodothyronine sulfatase activities in human and rat liver and placenta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Steroid receptor coactivator-1 deficiency causes variable alterations in the modulation of T(3)-regulated transcription of genes in vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Temperature homeostasis in transgenic mice lacking thyroid hormone receptor-alpha gene products

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Minireview: Pathophysiological importance of thyroid hormone transporters

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular mechanism of the inhibition of estradiol-induced endometrial epithelial cell proliferation by clomiphene citrate

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone is essential for maintenance and growth of uterine leiomyoma.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen-induced creatine kinase in the reproductive system of the immature female rat.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Physiological Action of Progesterone in Target Tissues*

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen receptor mutations in human disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Noncalcemic Actions of Vitamin D Receptor Ligands

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor coregulators and human disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular aspects of thyroid hormone actions

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Orphan nuclear receptors: from gene to function

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Hypothyroidism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New Millennium

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of long-term administration of desiccated thyroid on serum lipoprotein and cholesterol levels

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Physiologic activity of triiodo-and tetraiodo-thyroacetic acid in human myxedema

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Biochemical properties of the 1 alpha, 25-dihydroxyvitamin D3 cytosol receptors from human and chicken intestinal mucosa

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor coactivators and corepressors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Synthetic Glucocorticoids That Dissociate Transactivation and AP-1 Transrepression Exhibit Antiinflammatory Activityin Vivo

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Hormone selectivity in thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Patterns of liver gene expression governed by TRbeta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D: more than a "bone-a-fide" hormone.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptors interact with corepressors to regulate gene expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Sequence and expression of a functional chicken progesterone receptor.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Reproductive functions of progesterone receptors.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Unique properties of coactivator recruitment caused by differential binding of FK614, an anti-diabetic agent, to peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone resistance

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

https://api.crossref.org/works/10.1124%2FPR.112.006833

1 reference

7 January 2021

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Androgen insensitivity syndrome: clinical features and molecular defects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Clomiphene citrate elicits estrogen agonistic/antagonistic effects differentially via estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Merits and pitfalls of mifepristone in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormones and fetal neurological development

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A new derivative of triphenylethylene: effect on implantation and mode of action in rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Compounds exhibiting prolonged antioestrogenic and antifertility activity in mice and rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouse

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of a thyromimetic on apolipoprotein B-100 in rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The intranuclear localization of [6,7-3H]-oestradiol-17-beta in dimethylbenzanthracene-induced rat mammary adenocarcinoma and other tissues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Mode of action of I.C.I. 46,474 in preventing implantation in rats

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Tamoxifen as an anti-tumour agent: effect on oestrogen binding

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Interactions of oestradiol-17beta and tamoxifen in the uterus of the pregnant rat

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Association of oral calcitriol with improved survival in nondialyzed CKD.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Raloxifene: a review of its use in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D analogs: mechanism of action and therapeutic applications

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoids Pharmacology: Past, Present and Future

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Vitamin D receptor as a drug discovery target

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The pharmacology of LXR.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeutics

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease - implications for a new therapeutic approach.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Structure-activity relationship of nuclear receptor-ligand interactions

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Putative metabolic effects of the liver X receptor (LXR).

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Progesterone receptors: various forms and functions in reproductive tissues

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

New and emerging therapies for osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Calcitriol treatment is not effective in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1124%2FPR.112.006833

7 January 2021

Identifiers

DOI

10.1124/PR.112.006833

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23457206%20AND%20SRC:MED&resulttype=core&format=json